Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,381 | 231 | 99.8% |
| Education | $6.02 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $503.23 | 36 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $494.57 | 28 | $0 (2018) |
| Amgen Inc. | $335.91 | 16 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $302.61 | 18 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $237.91 | 16 | $0 (2018) |
| Lilly USA, LLC | $231.63 | 18 | $0 (2018) |
| GlaxoSmithKline, LLC. | $204.75 | 15 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $186.87 | 14 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $117.70 | 9 | $0 (2018) |
| Takeda Pharmaceuticals America, Inc. | $94.50 | 10 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $15.26 | 1 | Kowa Pharmaceuticals America, Inc. ($15.26) |
| 2018 | $1,612 | 108 | Novo Nordisk Inc ($267.66) |
| 2017 | $1,760 | 123 | AstraZeneca Pharmaceuticals LP ($248.59) |
All Payment Transactions
232 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/16/2019 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $15.26 | General |
| Category: Cardiovascular | ||||||
| 12/18/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: Central Nervous System (CNS) | ||||||
| 12/13/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/10/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET XR, STEGLATRO | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/29/2018 | ARBOR PHARMACEUTICALS, INC. | Edarbyclor (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/08/2018 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: Endocrinology | ||||||
| 11/05/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Diabetes | ||||||
| 11/01/2018 | Bausch Health US, LLC | MIGRANAL (Drug) | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: NEUROLOGY | ||||||
| 10/30/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $10.86 | General |
| Category: Central Nervous System (CNS) | ||||||
| 10/29/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/22/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/18/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: DIABETES | ||||||
| 10/12/2018 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: Obesity | ||||||
| 10/08/2018 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Neuroscience | ||||||
| 10/04/2018 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, BASAGLAR | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Diabetes | ||||||
| 09/28/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Diabetes | ||||||
| 09/24/2018 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: DIABETES | ||||||
| 09/20/2018 | Eisai Inc. | Belviq (Drug) | Food and Beverage | Cash or cash equivalent | $12.58 | General |
| Category: Nutrition and Weight Loss | ||||||
| 09/01/2018 | Bausch Health US, LLC | MIGRANAL (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: NEUROLOGY | ||||||
| 08/30/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: DIABETES | ||||||
| 08/28/2018 | GlaxoSmithKline, LLC. | ANORO (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: RESPIRATORY | ||||||
| 08/27/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/24/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: RESPIRATORY | ||||||
| 08/23/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 147 | 207 | $57,006 | $16,426 |
| 2022 | 8 | 487 | 676 | $125,309 | $48,248 |
| 2021 | 13 | 667 | 940 | $150,386 | $58,111 |
| 2020 | 13 | 679 | 972 | $146,283 | $48,659 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 70 | 107 | $33,170 | $9,226 | 27.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 83 | $18,260 | $5,123 | 28.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 17 | 17 | $5,576 | $2,076 | 37.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 167 | 324 | $76,362 | $26,141 | 34.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 101 | 101 | $24,745 | $12,957 | 52.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 72 | 92 | $14,710 | $4,766 | 32.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 33 | 34 | $3,440 | $2,314 | 67.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 40 | 41 | $2,296 | $1,150 | 50.1% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 45 | 53 | $2,809 | $512.95 | 18.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 13 | 13 | $767.00 | $366.22 | 47.7% |
| 81003 | Automated urinalysis test | Office | 2022 | 16 | 18 | $180.00 | $39.96 | 22.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 169 | 334 | $77,822 | $26,894 | 34.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 111 | 111 | $27,195 | $14,472 | 53.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 48 | 60 | $9,480 | $3,524 | 37.2% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 41 | 41 | $3,444 | $2,724 | 79.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 14 | 14 | $5,012 | $2,323 | 46.3% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 147 | 230 | $9,526 | $2,233 | 23.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 14 | 19 | $5,928 | $2,205 | 37.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 13 | 16 | $2,800 | $1,103 | 39.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $3,938 | $911.35 | 23.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 50 | 50 | $2,800 | $812.85 | 29.0% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 14 | 14 | $1,106 | $718.34 | 64.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 17 | 17 | $1,105 | $139.20 | 12.6% |
| 81003 | Automated urinalysis test | Office | 2021 | 18 | 23 | $230.00 | $51.75 | 22.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 155 | 331 | $77,123 | $22,813 | 29.6% |
About Dr. Beth Carlson, M.D
Dr. Beth Carlson, M.D is a Family Medicine healthcare provider based in Matthews, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1366443392.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Beth Carlson, M.D has received a total of $3,387 in payments from pharmaceutical and medical device companies, with $15.26 received in 2019. These payments were reported across 232 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($3,381).
As a Medicare-enrolled provider, Carlson has provided services to 1,980 Medicare beneficiaries, totaling 2,795 services with total Medicare billing of $171,443. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Matthews, NC
- Active Since 08/01/2005
- Last Updated 10/25/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1366443392
Products in Payments
- Victoza (Drug) $280.52
- FARXIGA (Drug) $245.67
- JARDIANCE (Drug) $160.14
- Repatha (Biological) $159.96
- Prolia (Biological) $155.53
- SYMBICORT (Drug) $140.97
- TRADJENTA (Drug) $132.97
- TOUJEO (Drug) $130.13
- PRALUENT (Drug) $124.50
- Saxenda (Drug) $120.56
- ANORO (Drug) $119.87
- TRULICITY (Drug) $115.97
- Trintellix (Drug) $103.35
- INVOKANA (Drug) $99.11
- BYDUREON (Drug) $94.48
- XARELTO (Drug) $81.74
- Belviq (Drug) $72.79
- Livalo (Drug) $51.62
- JANUVIA (Drug) $51.34
- SOLIQUA (Drug) $47.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Matthews
Gautam Patel, Md, MD
Family Medicine — Payments: $9,977
Dr. William Conner, Md, MD
Family Medicine — Payments: $5,349
Dr. Pasquale Baratta, Md, MD
Family Medicine — Payments: $2,578
Mishal Bhatt, M.d, M.D
Family Medicine — Payments: $1,675
Dr. Dixon Dehority, Md, MD
Family Medicine — Payments: $1,024
Dr. Tejal Patel, Md, MD
Family Medicine — Payments: $598.16